Ruth F. Oropeza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruth F. Oropeza has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alma R. Vázquez
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán 04510, D.F., México, and Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Cerro de las Campanas s. n., Querétaro, México
1 shared publication- Ana L. Pérez-Castorena
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán 04510, D.F., México
1 shared publication Emma Maldonado
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán 04510, D.F., México, and Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Cerro de las Campanas s. n., Querétaro, México
1 shared publication- Fernando Albericio
Peptide Science Laboratory, School of Chemistry and Physics University of KwaZulu‐Natal Durban South Africa
1 shared publication - Hortensia Rodríguez
Yachay Tech University
1 shared publication Mahinda Martínez
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán 04510, D.F., México, and Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Cerro de las Campanas s. n., Querétaro, México
1 shared publication
Latest Publications
- Open Access
3,4-Dihydro-2(1H)-Pyridones as Building Blocks of Synthetic Relevance
3,4-Dihydro-2(1H)-pyridones (3,4-DHPo) and their derivatives are privileged structures, which has increased their relevance due to their biological activity in front of a broad range of targets, but especially for their importance as synthetic precursors of a variety of compounds with marked biological activity. Taking into account the large number of contributions published over the years regarding this kind of heterocycle, here, we presented a current view of 3,4-dihydro-2(1H)-pyridones (3,4-DHPo). The review includes general aspects such as those related to nomenclature, synthesis, and biological activity, but also highlights the importance of DHPos as building blocks of other relevant structures. Additional to the conventional multicomponent synthesis of the mentioned heterocycle, nonconventional procedures are revised, demonstrating the increasing efficiency and allowing reactions to be carried out in the absence of the solvent, becoming an important contribution to green chemistry. Biological activities of 3,4-DHPo, such as vasorelaxant, anti-HIV, antitumor, antibacterial, and antifungal, have demonstrated this heterocycle’s potential in medicinal chemistry.
Open Access3,4-Dihydro-2(1H)-Pyridones as Building Blocks of Synthetic Relevance
3,4-Dihydro-2(1H)-pyridones (3,4-DHPo) and their derivatives are privileged structures, which has increased their relevance due to their biological activity in front of a broad range of targets, but especially for their importance as synthetic precursors of a variety of compounds with marked biological activity. Taking into account the large number of contributions published over the years regarding this kind of heterocycle, here, we presented a current view of 3,4-dihydro-2(1H)-pyridones (3,4-DHPo). The review includes general aspects such as those related to nomenclature, synthesis, and biological activity, but also highlights the importance of DHPos as building blocks of other relevant structures. Additional to the conventional multicomponent synthesis of the mentioned heterocycle, nonconventional procedures are revised, demonstrating the increasing efficiency and allowing reactions to be carried out in the absence of the solvent, becoming an important contribution to green chemistry. Biological activities of 3,4-DHPo, such as vasorelaxant, anti-HIV, antitumor, antibacterial, and antifungal, have demonstrated this heterocycle’s potential in medicinal chemistry.
- 29 June 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (7) , 1029-1033
Labdanes and Withanolides from Physalis coztomatl
Aerial parts of Physalis coztomatl afforded a new labdane diterpene, physacoztomatin (1), and five new withanolides, physacoztolides A−E (5−9). Six known compounds were also isolated. The structures of the new compounds were established after analyses of their spectroscopic data and by means of chemical transformations. X-ray diffraction analyses of 15-dehydrophysacoztomatin (2) and 5 confirmed the structures of 1 and 5. Labd-13(E)-ene-8α,15-diol (4) and physacoztomatin (1) represent the first labdane diterpenes isolated from the genus Physalis.
- 29 June 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (7) , 1029-1033
Labdanes and Withanolides from Physalis coztomatl
Aerial parts of Physalis coztomatl afforded a new labdane diterpene, physacoztomatin (1), and five new withanolides, physacoztolides A−E (5−9). Six known compounds were also isolated. The structures of the new compounds were established after analyses of their spectroscopic data and by means of chemical transformations. X-ray diffraction analyses of 15-dehydrophysacoztomatin (2) and 5 confirmed the structures of 1 and 5. Labd-13(E)-ene-8α,15-diol (4) and physacoztomatin (1) represent the first labdane diterpenes isolated from the genus Physalis.